Partnership Limited GP Biofund Israel Orbimed Novus Therapeutics, Inc
As of December 4, 2020
Partnership Limited GP Biofund Israel Orbimed Net Worth
- Net worth is estimated to be at least $60.53M
- Owns at least 73,650 units of Novus Therapeutics, Inc stock
- Sold an estimated value of $2.23M in the last 3 years at Novus Therapeutics, Inc
Partnership Limited GP Biofund Israel Orbimed Trading
- Largest purchase of shares was 646,204 units , worth over $2M on May 6, 2019
- Largest sale of shares was 103,200 units , worth over $2.23M on December 4, 2020
- In total has made about 4 transactions over 3 years
- Usually trades in May, with the busiest year in 2020
OrbiMed Israel GP Ltd, Partnership Limited GP BioFund Israel OrbiMed
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
Partnership Limited GP Biofund Israel Orbimed Mailing Address
- Mailing address is 601 Lexington Avenue, 54th Floor New York NY 1022-4629 NY
Novus Therapeutics, Inc Insider Trading
- The most recent transaction was 103,200 units sold on December 4, 2020 by Orbimed Israel GP Ltd and Partnership Limited GP Biofund Israel Orbimed worth over $2.23M
- In the last 3 years, insiders at Novus Therapeutics, Inc sold an estimated value of $2.63M and bought an estimated value of $7.31M
- The most active traders are Catherine C Turkel, President, Gregory J Flesher, Chief Executive Officer, and Jon Kuwahara, See Remarks
- Insider trading is most common in May, with the busiest year in 2019
Eledon Pharmaceuticals, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |